Market Alert: Strong Nuclear Tensions in South Asia Assessing the Fallout on Global Equity Markets
Ryman Healthcare’s (ASX: RYM) Annual Report for FY2024 provides an overview of the company’s operations from 1 April 2023 to 31 March 2024. The report adheres to the International Integrated Reporting Framework, NZX Listing Rules, and Corporate Governance Code. Key highlights include:
Financial Performance: Ryman reported an 18% increase in revenue to NZ$689.9 million, driven by growth in care, village, and deferred management fees. However, net profit after tax dropped significantly to NZ$4.8 million due to impairments and one-off costs.
Milestones and Achievements: The company celebrated its 40th anniversary, opened three new villages, and received several awards, including the Reader’s Digest Most Trusted Brand for the tenth time and the 'Operator of the Year' at the 2024 Asia-Pacific Eldercare Innovation Awards.
Community Engagement: Ryman raised over NZ$500,000 for the Fred Hollows Foundation, contributing to efforts against avoidable blindness.
Despite challenges, Ryman continues to set benchmarks in retirement living and aged care, focusing on restoring financial performance and shareholder returns.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Apr 28, 2025
Apr 28, 2025
Apr 24, 2025
Apr 24, 2025
Apr 23, 2025
Apr 14, 2025
Apr 11, 2025
Apr 11, 2025
Apr 10, 2025
Apr 10, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is based in Australia. The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
